Acrivon Therapeutics, Inc.

Develops precision cancer therapies by matching patients to drugs using its proteomics platform.

ACRV | US

Overview

Corporate Details

ISIN(s):: US0048901096
LEI:
Country:: United States of America
Address:: 480 ARSENAL WAY, SUITE 100, 2472 WATERTOWN
Website:: https://acrivon.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Acrivon Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in precision oncology. The company leverages its proprietary Acrivon Predictive Precision Proteomics (AP3) platform to develop targeted cancer therapies. The AP3 platform utilizes phosphoproteomics to analyze the biologic drivers of a patient's cancer, enabling the creation of predictive 'OncoSignature' tests. This method is designed to match drug candidates with patients whose tumors are most likely to respond, aiming to improve therapeutic outcomes beyond what is achievable with genomics. Acrivon's pipeline is led by ACR-368, a selective kinase inhibitor in Phase 2 clinical trials for various solid tumors. The company also advances its internally developed programs and seeks strategic partnerships to apply its AP3 platform to co-develop predictive tests for external drug candidates.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Acrivon Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Acrivon Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Acrivon Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
UNITED RENTALS, INC. World's largest equipment rental provider for construction and industrial worksites.	United States of America	URI
URANIUM ENERGY CORP A North American uranium producer using ISR to fuel the carbon-free nuclear industry.	United States of America	UEC
UR-ENERGY INC A U.S. uranium mining company using ISR methods to produce fuel for the clean nuclear power market.	United States of America	URG
Ureru Net Advertising Group Co.,Ltd. Direct marketing support for D2C e-commerce, boosting sales with patented tech & cloud services.	Japan	9235
Urteste S.A. Develops non-invasive urine tests to detect cancers early by measuring enzyme activity.	Poland	URT
VALIRX PLC Advancing oncology & women's health therapeutics and offering preclinical research services.	United Kingdom	VAL
VALUE GOLF Inc. A golf services hub offering reservations, solo player bookings, e-commerce, lessons, and tours.	Japan	3931
Value HR Co., Ltd. Offers a health management platform and consulting for corporate health insurance societies in Japan.	Japan	6078
VELTRA Corporation Global OTA for curated tours & experiences, focusing on travel to and from Japan.	Japan	7048
Very Good Tour Co.,Ltd. A South Korean travel company offering global tour packages, flights, hotels, and corporate travel.	South Korea	094850